Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build

Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health and changes regularly. See the Directory of published versions

: Regulated Authorization for Remsima 100 mg powder for concentrate for solution for infusion - XML Representation

Raw xml | Download



<RegulatedAuthorization xmlns="http://hl7.org/fhir">
  <id value="authorizatione3e5e78d4e002ed9e15b925cd546e20b"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: RegulatedAuthorization</b><a name="authorizatione3e5e78d4e002ed9e15b925cd546e20b"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource RegulatedAuthorization &quot;authorizatione3e5e78d4e002ed9e15b925cd546e20b&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-RegulatedAuthorization-uv-epi.html">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: id: EU/1/13/853/001 (use: OFFICIAL)</p><p><b>subject</b>: <a href="MedicinalProductDefinition-mpbe76bdf784deea6950583b234f789db2.html">MedicinalProductDefinition/mpbe76bdf784deea6950583b234f789db2</a></p><p><b>type</b>: Marketing Authorisation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072062)</span></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2018-06-21</p><p><b>holder</b>: <a href="Organization-mah-3c850a69e5187931f2198c5e63f933fe.html">Organization/mah-3c850a69e5187931f2198c5e63f933fe</a> &quot;Celltrion Healthcare Hungary Kft.&quot;</p><p><b>regulator</b>: <a href="Organization-mra-e3da03c458d6c0f3c5f1c39a2c6a1084.html">Organization/mra-e3da03c458d6c0f3c5f1c39a2c6a1084</a> &quot;European Medicines Agency&quot;</p></div>
  </text>
  <identifier>
    <use value="official"/>
    <system value="https://spor.ema.europa.eu/pmswi"/>
    <value value="EU/1/13/853/001"/>
  </identifier>
  <subject>🔗 
    <reference
               value="MedicinalProductDefinition/mpbe76bdf784deea6950583b234f789db2"/>
  </subject>
  <type>
    <coding>
      <system value="https://spor.ema.europa.eu/rmswi"/>
      <code value="100000072062"/>
      <display value="Marketing Authorisation"/>
    </coding>
  </type>
  <status>
    <coding>
      <system value="http://hl7.org/fhir/publication-status"/>
      <code value="active"/>
      <display value="Active"/>
    </coding>
  </status>
  <statusDate value="2018-06-21"/>
  <holder>🔗 
    <reference value="Organization/mah-3c850a69e5187931f2198c5e63f933fe"/>
  </holder>
  <regulator>🔗 
    <reference value="Organization/mra-e3da03c458d6c0f3c5f1c39a2c6a1084"/>
  </regulator>
</RegulatedAuthorization>